ClearStream CE marks PTCA catheter
This article was originally published in Clinica
Executive Summary
Enniscorthy, Ireland-based ClearStream Technologies has CE marked its latest percutaneous transluminal coronary angioplasty (PTCA) catheter for sale in Europe. The device, called FlexeCTO, is intended to treat chronic total occlusions (CTOs) in the coronary vasculature. It is a 0.014-inch over-the-wire balloon catheter designed to be the initial catheter used during the angioplasty procedure in cases where the blockage in the artery is distal or in tortuous arteries.